PRSS3 and cancer: Likewise in pancreatic cancer experimental studies, overexpression of PRSS3/mesotrypsin promoted cancer cell proliferation, invasion and metastasis, while knockdown of endogenous PRSS3/mesotrypsin reduced these malignant phenotypes21.